Abstract:ERK activation is enhanced by the scaffolding proteins KSR and MP1, localized near the cell membrane and late endosomes respectively, but little is known about their dynamic interplay. We develop here a mathematical model with ordinary differential equations to describe the dynamic activation of EGFR-ERK signaling under a conventional pathway without scaffolds, a KSR-scaffolded pathway, and an MP1-scaffolded pathway, and their impacts were examined under the influence of the endosomal regulators, Cbl-CIN85 and Endophilin A1. This new integrated model, validated against experimental results and computational constraints, shows that changes of ERK activation and EGFR endocytosis in response to EGF concentrations (i.e ligand sensitivity) depend on these scaffold proteins and regulators. The KSR-scaffolded and the conventional pathways act synergistically and are sensitive to EGF stimulation. When the KSR level is high, the sensitivity of ERK activation from this combined pathway remains low when Cbl-CIN85 level is low. But, such sensitivity can be increased with increasing levels of Endophilin if Cbl-CIN85 level becomes high. However, reduced KSR levels already present high sensitivity independent of Endophilin levels. In contrast, ERK activation by MP1 is additive to that of KSR but it shows little ligand-sensitivity under high levels of EGF. This can be partly reversed by increasing level of Endophilin while keeping Cbl-CIN85 level low. Further analyses showed that high levels of KSR affect ligand-sensitivity of EGFR endocytosis whereas MP1 ensures the robustness of endosomal ERK activation. These simulations constitute a multi-dimensional exploration of how EGF-dependent EGFR endocytosis and ERK activation are dynamically affected by scaffolds KSR and MP1, co-regulated by Cbl-CIN85 and Endophilin A1. Together, these results provide a detailed and quantitative demonstration of how regulators and scaffolds can collaborate to fine-tune the ligand-dependent sensitivity of EGFR endocytosis and ERK activation which could underlie differences during normal physiology, disease states and drug responses.

Regulation Of Egf-Stimulated Egf Receptor Endocytosis During M Phase

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

The EGF Receptor is Activated During Mitosis and Its Cell Signaling is Mediated Differently Than in Interphase (802.13)

EGF stimulates the activation of EGF receptors and the selective activation of major signaling pathways during mitosis.

An integrated model of epidermal growth factor receptor trafficking and signal transduction

Regulation Of Egf Receptor Signaling By The Marvel Domain-Containing Protein Cklfsf8

Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis

Single-molecule diffusion study of activated EGFR implicates its endocytic pathway

Phosphatidic acid-PKA signaling regulates p38 and ERK1/2 functions in ligand-independent EGFR endocytosis

Regulation of the Function of P-glycoprotein by Epidermal Growth Factor Through Phospholipase C

Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin

The clathrin adaptor complex-1 and Rab12 regulate post-golgi trafficking of WT epidermal growth factor receptor (EGFR)

[Regulation on EGFR Function Via Its Interacting Proteins and Its Potential Application].

Regulation of EGFR signal transduction by analogue-to-digital conversion in endosomes

Regulation of EGF-induced ERK/MAPK Activation and EGFR Internalization by G Protein-Coupled Receptor Kinase 2.

Application of EGFP-EGF fusions to explore mechanism of endocytosis of epidermal growth factor

Activation of epidermal growth factor receptor inhibits KCNQ2/3 current through two distinct pathways: membrane PtdIns(4,5)P2 hydrolysis and channel phosphorylation.

Effect of epidermal growth factor (EGF) on the biological characteristics of a cell line expressing EGF receptor on its membrane

Carboxy-Terminal Truncations Of Epidermal Growth-Factor (Egf) Receptor Affect Diverse Egf-Induced Cellular-Responses

Endocytic Regulation of TGF-β Signaling

Inhibition of the Ras-ERK Pathway in Mitotic COS7 Cells is Due to the Inability of EGFR/Raf to Transduce EGF Signaling to Downstream Proteins.